标普和纳斯达克内在价值 联系我们

Aspira Women's Health Inc. AWH NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.30
+3924.4%

共有 50 笔近期内部人交易记录记录,涉及 Aspira Women's Health Inc. (AWH), 包括 19 笔买入21 笔卖出. 内部人买入总额为 $76.5K 内部人卖出总额为 $4.45K.

近期活跃的重要内部人包括 Fraser John D, Cohen Jeffrey K, Buhle Michael William. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — AWH

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2025-09-12 Fraser John D Director 未知 900,633 - - -
2025-09-12 Cohen Jeffrey K Director 未知 450,318 - - -
2025-05-22 Buhle Michael William Chief Executive Officer 限制性股票授予 (RSU) 100,000 $0.07 $7K 100,000
2025-04-06 Hundorfean Cynthia D Director 未知 - - - -
2025-04-06 Fraser John D Director 未知 - - - 291,554
2025-04-02 Cohen Jeffrey K Director 未知 - - - 5,000
2025-03-31 Cavanaugh Stefanie L. Director 期权行权(卖出) 5,938 - - 5,937
2025-03-31 Fralick Celeste Rachelle Director 期权行权(卖出) 5,000 - - 5,000
2025-03-31 Herchuk Jannie Prestridge Director 期权行权(卖出) 8,438 - - 8,437
2025-03-31 Parnell Winfred Director 期权行权(卖出) 5,156 - - 5,156
2025-03-31 Ragard John Phillip Director 期权行权(卖出) 4,843 - - 4,844
2025-03-31 Beausang Ellen Director 期权行权 1,615 - - 1,615
2025-03-31 Vos Ellen O'connor Director 期权行权(卖出) 5,313 - - 5,312
2025-03-11 Beausang Ellen Director 限制性股票退回 (RSU) 6,458 - - 6,458
2025-03-06 Schuler Jack W 10 Percent Owner 知情买入 - $0.25 - -
2025-02-06 Beausang Ellen Director 未知 - - - -
2025-01-28 Buhle Michael William Officer 未知 - - - -
2025-01-28 Crawford James C Vice President of Finance 未知 800 $88.50 $70.8K -
2025-01-08 Milligan Sandra Interim CEO RSU 预扣税 6,356 $0.70 $4.45K 13,644
2024-12-31 Vos Ellen O'connor Director 期权行权(卖出) 5,312 - - 10,625
2024-12-31 Cavanaugh Stefanie L. Director 期权行权(卖出) 5,937 - - 11,875
2024-12-31 Milligan Sandra Interim CEO & President 期权行权(卖出) 20,000 - - -
2024-12-31 Fralick Celeste Rachelle Director 期权行权(卖出) 5,000 - - 10,000
2024-12-31 Herchuk Jannie Prestridge Director 期权行权(卖出) 8,437 - - 16,875
2024-12-31 Parnell Winfred Director 期权行权(卖出) 5,157 - - 10,312
2024-12-31 Ragard John Phillip Director 期权行权(卖出) 4,844 - - 9,687
2024-12-31 Milligan Sandra Interim CEO 期权行权 20,000 - - -
2024-11-21 Crawford James C Vice President of Finance 未知 1,000 $0.75 $750.00 -
2024-11-12 Milligan Sandra President 限制性股票授予 (RSU) 25,000 $0.84 $21K 25,000
2024-11-12 Kallassy John A Interim CFO 限制性股票授予 (RSU) 25,000 $0.84 $21K 25,000
2024-10-28 Sandford Nicole Chief Executive Officer 限制性股票授予 (RSU) 25,000 - - 25,000
2024-10-28 Milligan Sandra President 限制性股票授予 (RSU) 20,000 - - 20,000
2024-09-30 Cavanaugh Stefanie L. Director 期权行权(卖出) 5,938 - - 17,812
2024-09-30 Fralick Celeste Rachelle Director 期权行权(卖出) 5,000 - - 15,000
2024-09-30 Herchuk Jannie Prestridge Director 期权行权(卖出) 8,438 - - 25,312
2024-09-30 Parnell Winfred Director 期权行权(卖出) 5,156 - - 15,469
2024-09-30 Ragard John Phillip Director 期权行权 4,844 - - 14,531
2024-09-30 Vos Ellen O'connor Director 期权行权(卖出) 5,313 - - 15,937
2024-09-30 Ragard John Phillip Director 期权行权(卖出) 4,844 - - 14,531
2024-08-22 Vos Ellen O'connor Director 限制性股票授予 (RSU) 21,250 - - 21,250
2024-08-22 Cavanaugh Stefanie L. Director 限制性股票授予 (RSU) 23,750 - - 23,750
2024-08-22 Fralick Celeste Rachelle Director 限制性股票授予 (RSU) 20,000 - - 20,000
2024-08-22 Herchuk Jannie Prestridge Director 限制性股票授予 (RSU) 33,750 - - 33,750
2024-08-22 Parnell Winfred Director 限制性股票授予 (RSU) 20,625 - - 20,625
2024-08-22 Ragard John Phillip Director 限制性股票授予 (RSU) 19,375 - - 19,375
2024-08-15 Kallassy John A Officer 未知 - - - -
2024-08-15 Kallassy John A Interim CFO 限制性股票授予 (RSU) 25,000 $1.10 $27.5K 25,000
2024-08-12 Vos Ellen O'connor Director 限制性股票授予 (RSU) 16,593 - - 52,739
2024-08-12 Cavanaugh Stefanie L. Director 限制性股票授予 (RSU) 16,804 - - 54,976
2024-08-12 Fralick Celeste Rachelle Director 限制性股票授予 (RSU) 15,381 - - 40,665
知情交易 — 公开市场买卖(最具参考价值) 非知情买入 — 奖励、期权行权、转换 非知情卖出 — 税务代扣、归属出售 中性 — 礼赠、信托、到期
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言